Thomas Soloway
2018
In 2018, Thomas Soloway earned a total compensation of $525.3K as Executive Vice President and Chief Financial Officer at Audentes Therapeutics, a 81% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $127,360 |
|---|---|
| Salary | $397,950 |
| Total | $525,310 |
Soloway received $398K in salary, accounting for 76% of the total pay in 2018.
Soloway also received $127.4K in non-equity incentive plan.
Rankings
In 2018, Thomas Soloway's compensation ranked 11,713th out of 14,244 executives tracked by ExecPay. In other words, Soloway earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,713 out of 14,244 | 18th |
Division Manufacturing | 4,727 out of 5,765 | 18th |
Major group Chemicals And Allied Products | 1,790 out of 2,128 | 16th |
Industry group Drugs | 1,524 out of 1,817 | 16th |
Industry Biological Products, Except Diagnostic Substances | 293 out of 339 | 14th |
Source: SEC filing on April 26, 2019.
Soloway's colleagues
We found four more compensation records of executives who worked with Thomas Soloway at Audentes Therapeutics in 2018.